Product Information
VERAPAMIL ER 120 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1905 per EA under NDC 68462029201. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
120 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462029201
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090700On Market Since
8/5/2011
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL ER 120 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 22.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1905 per EA |
|---|---|
| All-time high | $0.3647 (Jun 16, 2021) |
| All-time low | $0.1442 (Dec 19, 2018) |
| 52-week high | $0.2492 |
| 52-week low | $0.1905 |
| Median price | $0.2265 |
| Average price | $0.2345 |
| Largest weekly change | +29.2% (Feb 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VERAPAMIL ER 120 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL ER 120 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1905 per EA (NDC 68462029201), effective Jun 24, 2026.
How has the price of VERAPAMIL ER 120 MG TABLET changed over time?
Over the history we have for it, the NADAC for VERAPAMIL ER 120 MG TABLET has declined 22.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VERAPAMIL ER 120 MG TABLET?
Since Nov 28, 2013, the NADAC for VERAPAMIL ER 120 MG TABLET has ranged from a low of $0.1442 (Dec 19, 2018) to a high of $0.3647 (Jun 16, 2021), with a median of $0.2265 per EA.
Are there cheaper alternatives to VERAPAMIL ER 120 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as VERAPAMIL ER 120 MG TABLET, but none are currently priced below it.
Who manufactures VERAPAMIL ER 120 MG TABLET?
VERAPAMIL ER 120 MG TABLET (NDC 68462029201) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification